The present invention relates to kinetic resolution of racemic δ-hydroxyl ester via asymmetric catalytic hydrogenation and an application thereof. In the presence of chiral spiro pyridyl phosphine ligand Iridium catalyst and base, racemic δ-hydroxyl esters were subjected to asymmetric catalytic hydrogenation to obtain extent optical purity chiral δ-hydroxyl esters and corresponding 1,5-diols. The method is a new, efficient, highly selective, economical, desirably operable and environmentally friendly method suitable for industrial production. An optically active chiral δ-hydroxyl ester and 1,5-diols can be obtained at very high enantioselectivity and yield with relatively low usage of catalyst. The chiral δ-hydroxyl ester and 1,5-diols obtained by using the method can be used as a critical raw material for asymmetric synthesis of chiral drugs (R)-lisofylline and natural drugs (+)-civet, (−)-indolizidine 167B and (−)-coniine.

The present invention provides one method for the preparation of pharmaceutically acceptable chlorogenic acid, which comprises the following steps: a. Treating the sample aqueous solution; b. Freezing; c. Thawing and filtering; d. Treating the residue organic phase; e. Concentrating and crystallizing; f. Choosing the number of times to repeat steps a-e according to the variability of chlorogenic acid content in samples; g. Drying. If the chlorogenic acid extract is isolated and purified using this method, water-soluble impurities and liposoluble impurities can be well removed, that allows the impurity content of final products has fulfilled the requirements for medicine; meanwhile, the procedures of this method are simple, and organic solvents can be recycled for further use, with low cost. This method can be applied for the further isolation and purification of chlorogenic acid extract obtained by various ways, especially for the preparation of pharmaceutically acceptable chlorogenic acid.

The present invention provides one method for the preparation of pharmaceutically acceptable chlorogenic acid, which comprises the following steps: a. Treating the sample aqueous solution; b. Freezing; c. Thawing and filtering; d. Treating the residue organic phase; e. Concentrating and crystallizing; f. Choosing the number of times to repeat steps a-e according to the variability of chlorogenic acid content in samples; g. Drying. If the chlorogenic acid extract is isolated and purified using this method, water-soluble impurities and liposoluble impurities can be well removed, that allows the impurity content of final products has fulfilled the requirements for medicine; meanwhile, the procedures of this method are simple, and organic solvents can be recycled for further use, with low cost. This method can be applied for the further isolation and purification of chlorogenic acid extract obtained by various ways, especially for the preparation of pharmaceutically acceptable chlorogenic acid.

A process can be used for producing optical molding materials on the basis of methyl methacrylate (MMA). The MMA produced by an optimized method and the molding materials feature in particular a very low yellowness index. This MMA has been produced by direct oxidative esterification of methacrolein. An optimized workup of the reactor output from the oxidative esterification of methacrolein can be used for removing particularly discoloring byproducts. This process moreover has the advantage that fewer demands are placed on plant apparatus configuration.

A process can be used for producing optical molding materials on the basis of methyl methacrylate (MMA). The MMA produced by an optimized method and the molding materials feature in particular a very low yellowness index. This MMA has been produced by direct oxidative esterification of methacrolein. An optimized workup of the reactor output from the oxidative esterification of methacrolein can be used for removing particularly discoloring byproducts. This process moreover has the advantage that fewer demands are placed on plant apparatus configuration.

A process is useful for producing optical molding materials on the basis of methyl methacrylate (MMA), wherein this MMA has been produced by an optimized method and the molding materials feature in particular a very low yellowness index. This MMA has been produced by direct oxidative esterification of methacrolein. In particular, an optimized workup of the reactor output from the oxidative esterification of methacrolein is useful for removing particularly discoloring byproducts. This process moreover has the advantage that fewer demands than described in related art are placed on plant apparatus configuration.

A process is useful for producing optical molding materials on the basis of methyl methacrylate (MMA), wherein this MMA has been produced by an optimized method and the molding materials feature in particular a very low yellowness index. This MMA has been produced by direct oxidative esterification of methacrolein. In particular, an optimized workup of the reactor output from the oxidative esterification of methacrolein is useful for removing particularly discoloring byproducts. This process moreover has the advantage that fewer demands than described in related art are placed on plant apparatus configuration.

Methods and systems for the production and isolation of fatty acid methyl esters (FAMEs) from a lipid source are described. The method includes extracting a lipid from a lipid source and transesterifying the lipid into a FAME. The method may also include fractionating the FAME from the system. A method of selectively transesterifying a lipid into a FAME is also described.

Methods and systems for the production and isolation of fatty acid methyl esters (FAMEs) from a lipid source are described. The method includes extracting a lipid from a lipid source and transesterifying the lipid into a FAME. The method may also include fractionating the FAME from the system. A method of selectively transesterifying a lipid into a FAME is also described.

Disclosed is a method of reducing the ultraviolet-light absorbing properties of a composition comprising dioctyl phthalate, the method comprising (a) obtaining a composition comprising dioctyl phthalate and phthalide, wherein said composition has an absorbance of greater than 0.1 at a wavelength of about from 230 to 360 nm, (b) contacting the composition with activated carbon, silica gel, or diatomaceous earth, for a sufficient amount of time to allow the phthalide to contact the activated carbon, silica gel, or diatomaceous earth, and (c) removing the composition from the activated carbon, silica gel, or diatomaceous earth, wherein the composition obtained from step (c) has an absorbance equal to or less than about 0.1 at a wavelength of about from 230 to 360 nm and has a reduced amount of phthalide when compared with the composition from step (a).